Author:
Valdés Gloria,Acuña Stephanie,Schneider Daniela,Ortíz Rita,Padilla Oslando
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference55 articles.
1. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005;99(1):6–38.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524–6.
3. Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ. Effect of bradykinin- receptor blockade on the response to angiotensin-converting-enzyme inhibitor innormotensive and hypertensive subjects. N Engl J Med. 1998;339(18):1285–92.
4. Cockcroft JR, Chowienczyk PJ, Brett SE, Bender N, Ritter JM. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist. Br J Clin Pharmacol. 1994;38(4):317–21.
5. Nunes RAB, Lima LB, Tanaka NI, da Costa PA, Krieger JE, Mansur AJ. Genetic associations of bradykinin type 2 receptor, alpha-adrenoceptors and endothelial nitric oxide synthase with blood pressure and left ventricular mass in outpatients without overt heart disease. Int J Cardiol Heart Vasc. 2018;21:45–9.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献